ALLMedicine™ Cardiovascular Risk Management Center
Research & Reviews 160 results
https://doi.org/10.1161/HYPERTENSIONAHA.122.19693
Hypertension (Dallas, Tex. : 1979); Picone DS, Stoneman E et. al.
Aug 2nd, 2022 - Accurate blood pressure (BP) measurement is critical for optimal cardiovascular risk management. Age-related trajectories for cuff-measured BP accelerate faster in women compared with men, but whether cuff BP represents the intraarterial (invasive...
https://emedicine.medscape.com/article/333221-treatment
Jul 22nd, 2022 - Medical Care Patients with antiphospholipid syndrome (APS) may be evaluated in an outpatient setting. Inpatient evaluation is required if the patient presents with a significant clinical event. Patients with catastrophic APS (CAPS) require intense...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272927
The European Journal of General Practice; Jakobs K, Lautan L et. al.
Jul 8th, 2022 - Patients with severe mental illness (SMI) or receiving treatment with antipsychotics (APs) have an increased risk of cardiovascular disease. Cardiovascular risk management (CVRM) increasingly depends on general practitioners (GPs) because of the s...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254685
Journal of Foot and Ankle Research; Chuter V, Quigley F et. al.
Jul 6th, 2022 - Peripheral artery disease (PAD) is implicated in up to 50% of diabetes-related foot ulcers (DFU) and significantly contributes to morbidity and mortality in this population. An evidence-based guideline that is relevant to the national context incl...
https://clinicaltrials.gov/ct2/show/NCT01783145
May 18th, 2022 - Rationale: Since the introduction of cisplatin, metastatic testicular cancer (TC) has become a highly curable disease. Successfully treated TC patients have a small chance of a relapse. In case of a relapse, early treatment will improve outcome. T...
Drugs 1,334 results see all →
Clinicaltrials.gov 18 results
https://clinicaltrials.gov/ct2/show/NCT01783145
May 18th, 2022 - Rationale: Since the introduction of cisplatin, metastatic testicular cancer (TC) has become a highly curable disease. Successfully treated TC patients have a small chance of a relapse. In case of a relapse, early treatment will improve outcome. T...
https://clinicaltrials.gov/ct2/show/NCT03190382
Apr 8th, 2022 - Peripheral arterial disease (PAD) is a burdensome condition that affects 10% of the population and increases to 15-20% among those ≥70 years. In PAD, the underlying pathophysiologic process, atherosclerosis, presents itself as blockages in patient...
https://clinicaltrials.gov/ct2/show/NCT02771873
Jan 19th, 2021 - STUDY AIMS: AIM 1. To identify barriers to implementing an integrated cardiovascular risk management program in families of individuals with a positive history CHD. AIM 2. To assess the effectiveness of an integrated cardiovascular risk management...
https://clinicaltrials.gov/ct2/show/NCT04257968
Feb 6th, 2020 - Problem: With increasing numbers of cancer survivors, strategies to prevent long-term complications in cancer patients become more important. Adolescent and Young Adult (AYA) Head and Neck Cancer survivors treated with radiotheray (RT) are prone t...
https://clinicaltrials.gov/ct2/show/NCT02110251
Jul 25th, 2019 - Patients with peripheral arterial disease with symptoms of critical ischemia or reduced tissue loss have a very high mortality and morbidity rate. So far, treatment strategies focused on the preservation of life and limb by an open surgical or end...
News 36 results
https://www.medscape.com/viewarticle/969766
Mar 7th, 2022 - The prevalence of metabolic syndrome varies according to how it is defined, but approximately 30% of psoriatic arthritis (PsA) patients met the criteria in a cohort study of 724 individuals, as did approximately 23%-63% of patients across multiple...
https://www.mdedge.com/dermatology/article/252456/psoriatic-arthritis/one-third-psoriatic-arthritis-patients-could-have
Heidi Splete
Mar 4th, 2022 - The prevalence of metabolic syndrome varies according to how it is defined, but approximately 30% of psoriatic arthritis (PsA) patients met the criteria in a cohort study of 724 individuals, as did approximately 23%-63% of patients across multiple.
https://www.medscape.com/viewarticle/969087
Feb 24th, 2022 - New recommendations from the European Alliance of Associations for Rheumatology (EULAR) provide both broad and detailed advice for cardiovascular risk management in various rheumatic and musculoskeletal diseases (RMDs), many of which can lead to a...
https://www.medscape.com/viewarticle/962914
Nov 15th, 2021 - LONDON - Tighter low-density lipoprotein (LDL) targets, should be the aim in very high-risk patients, using a combination of therapies in a new era of ‘ones not twos’ (in terms of mmol/L), according to experts in lipid and cardiovascular risk mana...
https://www.onclive.com/view/improvements-in-cardiovascular-risk-management-needed-for-mpn
Jun 11th, 2021 - Although cardiovascular health of patients with myeloproliferative neoplasms (MPN) was relatively good, an estimated 11% to 22% of patients were not prescribed appropriate medications for management of comorbidities associated with thrombotic risk...